AdAlta Limited (1AD.AX)
AUD 0.02
(-6.25%)
AUD 0.02
(-6.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -5.26 Million AUD | 36.91% |
| 2023 | -8.34 Million AUD | -39.03% |
| 2022 | -5.99 Million AUD | -10.72% |
| 2021 | -5.41 Million AUD | 7.22% |
| 2020 | -5.83 Million AUD | 38.71% |
| 2019 | -9.52 Million AUD | -61.98% |
| 2018 | -5.88 Million AUD | -22.54% |
| 2017 | -4.8 Million AUD | -151.32% |
| 2016 | -1.91 Million AUD | -44.62% |
| 2015 | -1.32 Million AUD | -5.75% |
| 2014 | -1.24 Million AUD | -64.25% |
| 2013 | -760.3 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -7.06 Million AUD | 15.32% |
| 2024 Q4 | -2.32 Million AUD | 0.0% |
| 2024 Q2 | -4.08 Million AUD | 0.0% |
| 2023 Q4 | -4.43 Million AUD | 0.0% |
| 2023 FY | -8.34 Million AUD | -39.03% |
| 2023 Q2 | -3.9 Million AUD | 0.0% |
| 2022 Q4 | -2.41 Million AUD | 0.0% |
| 2022 Q2 | -3.58 Million AUD | 0.0% |
| 2022 FY | -5.99 Million AUD | -10.72% |
| 2021 Q4 | -4.12 Million AUD | 0.0% |
| 2021 Q2 | -4.34 Million AUD | 0.0% |
| 2021 FY | -5.41 Million AUD | 7.22% |
| 2020 Q2 | -6.08 Million AUD | 0.0% |
| 2020 Q4 | -2.96 Million AUD | 0.0% |
| 2020 FY | -5.83 Million AUD | 38.71% |
| 2019 FY | -9.52 Million AUD | -61.98% |
| 2019 Q2 | -3.6 Million AUD | 0.0% |
| 2019 Q4 | -5.88 Million AUD | 0.0% |
| 2018 Q4 | -492.81 Thousand AUD | 0.0% |
| 2018 Q2 | -3.36 Million AUD | 0.0% |
| 2018 FY | -5.88 Million AUD | -22.54% |
| 2017 Q2 | -2.26 Million AUD | 0.0% |
| 2017 FY | -4.8 Million AUD | -151.32% |
| 2017 Q4 | -737.75 Thousand AUD | 0.0% |
| 2016 Q1 | -344.2 Thousand AUD | 0.0% |
| 2016 Q4 | -483.54 Thousand AUD | 0.0% |
| 2016 Q2 | -688.41 Thousand AUD | -100.0% |
| 2016 FY | -1.91 Million AUD | -44.62% |
| 2015 FY | -1.32 Million AUD | -5.75% |
| 2014 FY | -1.24 Million AUD | -64.25% |
| 2013 FY | -760.3 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 154.151% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -260.599% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 11.395% |
| Biome Australia Limited | -1.91 Million AUD | -175.01% |
| Patrys Limited | -3.53 Million AUD | -48.668% |
| Orthocell Limited | -11.68 Million AUD | 54.956% |
| Imugene Limited | -140.93 Million AUD | 96.267% |
| Noxopharm Limited | -7.53 Million AUD | 30.171% |
| PYC Therapeutics Limited | -38.85 Million AUD | 86.459% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 57.256% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 26.784% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 27.241% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 40.263% |
| CSL Limited | 5.64 Billion AUD | 100.093% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 26.852% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -71.809% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 110.706% |
| Starpharma Holdings Limited | -15.15 Million AUD | 65.291% |
| Nanollose Limited | -1.24 Million AUD | -320.986% |
| Memphasys Limited | -2.7 Million AUD | -94.586% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -146.603% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -155.844% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -18.907% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 64.207% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -83.09% |
| Race Oncology Limited | -13.38 Million AUD | 60.677% |
| Nyrada Inc. | -4.56 Million AUD | -15.377% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | 79.004% |
| PharmAust Limited | -6.65 Million AUD | 20.981% |
| Immutep Limited | -44.93 Million AUD | 88.291% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 88.256% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 73.157% |
| BTC Health Limited | 1.05 Million AUD | 598.594% |
| Acrux Limited | -9.83 Million AUD | 46.496% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 102.329% |
| Biotron Limited | -5.15 Million AUD | -2.144% |
| Tissue Repair Ltd | -4.87 Million AUD | -7.909% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 88.855% |
| Hexima Limited | -1 Million AUD | -421.595% |
| AnteoTech Limited | -11.72 Million AUD | 55.131% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 91.919% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 76.139% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -14.652% |
| Actinogen Medical Limited | -12.83 Million AUD | 59.019% |
| Immuron Limited | -5.8 Million AUD | 9.3% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 7.223% |